W O Bechstein - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

W O Bechstein

Showing results (141-150 of 351) with videos related to

Pageof 36

Sort By:

Langenbeck'S Archives of Surgery|August 25, 2000

Primary and secondary hepatic manifestation of neuroendocrine tumorsA Pascher, T Steinmüller, C Radke, et al.

Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1994

Neurotoxicity after orthotopic liver transplantation in cyclosporin A- and FK 506-treated patientsA R Mueller, K P Platz, N Schattenfroh, et al.

Seminars in Thrombosis and Hemostasis|January 1, 1993

Changes in urokinase-type plasminogen activator in orthotopic liver transplantationG Himmelreich, G Dooijewaard, P Breinl, et al.

Transplantation|February 24, 2001

Comparison of famciclovir and lamivudine in the long-term treatment of hepatitis B infection after liver transplantationN Rayes, D Seehofer, U Hopf, et al.

Thrombosis and Haemostasis|January 11, 1993

Evolution of urokinase-type plasminogen activator (u-PA) and tissue-type plasminogen activator (t-PA) in orthotopic liver transplantation (OLT)G Himmelreich, G Dooijewaard, P Breinl, et al.

Transplantation Proceedings|October 1, 1987

Surgical complications in 200 consecutive liver transplantsW O Bechstein, G Blumhardt, B Ringe, et al.

Annals of Transplantation|June 13, 2000

Preemptive therapy in CMV-antigen positive patients after liver transplantation--a prospective trialN Rayes, H Oettle, C A Schmidt, et al.

Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1994

Selection of small hepatocellular carcinoma improves long-term results of hepatic transplantation for malignancyW O Bechstein, G Blumhardt, H Lobeck, et al.

Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|September 9, 2011

[Blood-borne infections and the pregnant health care worker. Risks and preventive measures]S Wicker, H F Rabenau, A E Haberl, et al.

Transplantation Proceedings|March 20, 1999

Treatment of hepatitis B-reinfection or de novo-infection after liver transplantation with famciclovir--how effective is it?N Rayes, R Neuhaus, U Naumann, et al.

Pageof 36

Search research articles

Showing results (141-150 of 351) with videos related to

Sort By:

Pageof 36

Langenbeck'S Archives of Surgery|August 25, 2000

Primary and secondary hepatic manifestation of neuroendocrine tumorsA Pascher, T Steinmüller, C Radke, et al.

Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1994

Neurotoxicity after orthotopic liver transplantation in cyclosporin A- and FK 506-treated patientsA R Mueller, K P Platz, N Schattenfroh, et al.

Seminars in Thrombosis and Hemostasis|January 1, 1993

Changes in urokinase-type plasminogen activator in orthotopic liver transplantationG Himmelreich, G Dooijewaard, P Breinl, et al.

Transplantation|February 24, 2001

Comparison of famciclovir and lamivudine in the long-term treatment of hepatitis B infection after liver transplantationN Rayes, D Seehofer, U Hopf, et al.

Thrombosis and Haemostasis|January 11, 1993

Evolution of urokinase-type plasminogen activator (u-PA) and tissue-type plasminogen activator (t-PA) in orthotopic liver transplantation (OLT)G Himmelreich, G Dooijewaard, P Breinl, et al.

Transplantation Proceedings|October 1, 1987

Surgical complications in 200 consecutive liver transplantsW O Bechstein, G Blumhardt, B Ringe, et al.

Annals of Transplantation|June 13, 2000

Preemptive therapy in CMV-antigen positive patients after liver transplantation--a prospective trialN Rayes, H Oettle, C A Schmidt, et al.

Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1994

Selection of small hepatocellular carcinoma improves long-term results of hepatic transplantation for malignancyW O Bechstein, G Blumhardt, H Lobeck, et al.

Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|September 9, 2011

[Blood-borne infections and the pregnant health care worker. Risks and preventive measures]S Wicker, H F Rabenau, A E Haberl, et al.

Transplantation Proceedings|March 20, 1999

Treatment of hepatitis B-reinfection or de novo-infection after liver transplantation with famciclovir--how effective is it?N Rayes, R Neuhaus, U Naumann, et al.

Pageof 36